BiotechTube
ClearPoint Neuro

ClearPoint Neuro

Solana Beach, United States· Est.

ClearPoint Neuro's mission is to improve and restore quality of life by enabling therapies for complex neurological disorders with pinpoint accuracy. The company has established itself as an industry leader by supporting over 7,000 procedures and partnering with more than 60 biologics and drug delivery companies. Its integrated platform combines real-time MRI guidance with specialized hardware and software, facilitating a seamless transition from pre-clinical research to clinical trials and commercial procedures. ClearPoint focuses exclusively on the neuro space, providing critical infrastructure for the advancing fields of gene therapy, cell therapy, and targeted drug delivery to the central nervous system.

clearpointneuro.com

Private Company

Total funding raised: $25M

AI Company Overview

ClearPoint Neuro's mission is to improve and restore quality of life by enabling therapies for complex neurological disorders with pinpoint accuracy. The company has established itself as an industry leader by supporting over 7,000 procedures and partnering with more than 60 biologics and drug delivery companies. Its integrated platform combines real-time MRI guidance with specialized hardware and software, facilitating a seamless transition from pre-clinical research to clinical trials and commercial procedures. ClearPoint focuses exclusively on the neuro space, providing critical infrastructure for the advancing fields of gene therapy, cell therapy, and targeted drug delivery to the central nervous system.

NeurologyNeurosurgery

Technology Platform

An integrated hardware and software platform for real-time MRI-guided navigation and precise delivery of therapeutics, devices, and biologics to the brain and spine. It combines the ClearPoint Maestro software suite with specialized disposable cannulas and fixation frames.

Funding History

2
Total raised:$25M
PIPE$15M
IPO$10M

Opportunities

ClearPoint Neuro's primary growth opportunities lie in the expansion of its partner-enabled services as the pipeline of CNS-targeted gene and cell therapies grows.
The commercialization of new platform features, like the infusion coverage tool and branching delivery device, can open new markets and procedure types.
Furthermore, geographic expansion into new neurosurgery centers globally represents a direct path to increased hardware and disposable sales.

Risk Factors

Key risks include dependence on the success and regulatory approval of partners' therapeutic pipelines, potential competition from larger medical device companies entering the MRI-guided surgery space, and the ongoing challenge of securing adequate reimbursement from healthcare payers for advanced navigation procedures.
Execution risk in managing its dual business model is also present.

Competitive Landscape

ClearPoint Neuro's main competitors are large surgical navigation companies like Medtronic (StealthStation) and Brainlab, which dominate the broader market but lack integrated real-time MRI guidance. ClearPoint's differentiation is its dedicated, real-time intraprocedural MRI platform designed specifically for the most complex neuro-interventions, coupled with a unique service offering for drug development partners.

More companies in Neuroscience & CNS →More companies in United States →